Meilleure Health International Industry Group (2327) Fundamentals 2026 — P/E 26.9x, Revenue Analysis | SniperIQ
Meilleure Health International Industry Group (2327) is a HK-listed Industrials company in Conglomerates with a market capitalization of HK
7M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Meilleure Health International Industry Group's market cap?
Meilleure Health International Industry Group (2327) has a market capitalization of approximately HK
What is Meilleure Health International Industry Group's P/E ratio?
Meilleure Health International Industry Group's trailing twelve-month P/E ratio is 26.9x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Meilleure Health International Industry Group?
Meilleure Health International Industry Group runs a net profit margin of 104.0%, a gross margin of 62.0%, and an operating margin of -26.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Meilleure Health International Industry Group generate?
Meilleure Health International Industry Group reported revenue of HK